Empiric distributions [PK / PD]

posted by Helmut Homepage – Vienna, Austria, 2012-03-21 17:18 (4413 d 23:07 ago) – Posting: # 8306
Views: 8,545

Dear all,

Detlew wrote here:

❝ The whole discussion up to here depends on the assumption of log-normality. If this is a reasonable assumption for measures of fluctuation like PTF or swing is left to you.

Good question. For Cmax and AUC there’s a consensus that these metrics are lognormal. See also the empiric distribution of AUCs of methylphenidate in 405 subjects in this presentation which agrees with pharmacokinetic considerations and lead to a multiplicative model (or additive on logtransformed data). Steinijans et al.* state about MR theophylline:

The choice of the multiplicative model and hence the ratio analysis for the plateu time T75% Cmax is motivated by the distribution analysis of the plateau time for the test formulation Euphylong® in n = 102 healthy subjects and n = 85 patients presenting with obstructive pulmonary diseases. The logarithmic normal distribution was superior to the normal distribution (data on file).
(my emphasis)

Cmax/AUC, %PTF, and Swing were also analysed based on logtransformed data without further justification.

I looked at my MPH MR data (10–60 mg, SD/MD; linear PK). Data of 303 subjects (HVD, MRT, Cmax/AUC) and 276 subjects (t75%):





Interesting, isn’t it?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,988 posts in 4,825 threads, 1,649 registered users;
41 visitors (0 registered, 41 guests [including 15 identified bots]).
Forum time: 17:25 CEST (Europe/Vienna)

As soon as we abandon our own reason, and are content
to rely upon authority, there is no end to our troubles.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz